International safety notice

Urgent Field Safety Notice for Atellica IM Erythropoietin (EPO) Assay; ADVIA Centaur Erythropoietin (EPO) Assay; by Siemens Healthcare Diagnostics Inc. Tarrytown

Germany / BfArM · DEU · Feb 29, 2024

Key facts

Title Urgent Field Safety Notice for Atellica IM Erythropoietin (EPO) Assay; ADVIA Centaur Erythropoietin (EPO) Assay; by Siemens Healthcare Diagnostics Inc. Tarrytown
Regulator Germany / BfArM
Country DEU
Brand Atellica IM Erythropoietin (EPO) Assay; ADVIA Centaur Erythropoietin (EPO) Assay;
Manufacturer Siemens Healthcare Diagnostics Inc. Tarrytown
Models 2023-02-09, 00630414010380, 2024-02-05, 53984040, 55439041, 53982039, 55443042, 20240820, 20240205, 00630414245775, 20230209, 2023-02-08 and 7 more
Date Feb 29, 2024
Regulator page bfarm.de

At a glance

  • No Recall
  • No Field safety notice

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About International device safety notices

Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.

Source: National medical device regulators (as listed), compiled by Orca1

Browse all International device safety notices